Abstract. Human polymorphonuclear leukocytes (PMN) released large quantities of hydrogen peroxide in response to tumor necrosis factor, but only when the cells were adherent to surfaces coated with extracellular matrix proteins. The PMN did not respond when exposed to cytokines and matrix proteins in suspension, or when exposed to cytokines while adherent to surfaces coated with stearic acid. PMN from children with genetic deficiency of the CDll/CD18 integrins underwent a normal respiratory burst upon adherence to uncoated polystyrene, but not in response to tumor necrosis factor when tested on polystyrene that was coated with serum, fibronectin, vitronectin, fibrinogen, thrombospondin, or laminin. Anti-CD18 antibodies, alone of sixteen antibodies tested, induced a similar defect in PMN from normal donors, when the PMN were tested on surfaces coated with serum, fibrinogen, thrombospondin, or laminin; no defect was induced by the anti-CD18 monoclonal antibody IB4 in normal PMN tested on surfaces coated with fibronectin or vitronectin. Thus, for cytokines to induce a respiratory burst in PMN, the cells must be able to use CDll/CD18 integrins and must interact with matrix proteins in the solid phase. CDll/CD18, which is already known to serve as a receptor for fibrinogen, may also be a receptor for thrombospondin and laminin. Finally, receptor(s) exist on PMN for fibronectin and vitronectin which are not blocked by the anti-CD18 antibody IB4 but which are nonetheless CDll/CD18 dependent.
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H
UMAN polymorphonuclear leukocytes (PMN) ~ can undergo a large respiratory burst in response to subnanomolar concentrations of tumor necrosis factorct (TNFo0, TNF/$, colony stimulating factor for granulocytes and macrophages (CSF-GM), or colony stimulating factor for granulocytes (CSF-G), but only if the PMN are adherent to surfaces coated with plasma, serum, or proteins of extracellular matrix (40, 41) . There are few if any other instances in which adherence of PMN capacitates them to respond to stimuli that are otherwise ineffective. The goal of the present study was to determine if capacitation by adherence requires ligation of specific adhesion receptors.
Integrins are a superfamily of heterodimeric, transmembrahe glycoproteins which act as receptors for various glycoproteins of extracellular matrix or cell surface (33) . Interaction of integrins with surface-bound ligands supports adhesion 1. Abbreviations used in this paper: CSF-G, colony stimulating factor for granulocytes; CSF-GM, colony stimulating factor for granulocytes/macrophages; FBG, fibrinogen; FN, fibronectin; KRPG, Krebs-Ringer phosphate buffer with glucose; LAD, leukocyte adhesion deficiency; LAM, laminin; PMA, phorhol myristate acetate; PMN, neutrophilic polymorphonuclear leukoeytes; r, recombinant; TNE tumor necrosis factor; TSP, thrombospondin; VN, vitronectin. of phagocytes and their spreading, diapedesis, and phagocytosis. Engagement of phagocyte integrins apparently does not trigger secretion, for example of hydrogen peroxide (23, 66) or arachidonate (1) , although exposure of macrophages to an anti-integrin antibody for 1-3 d did increase the amount of hydrogen peroxide released subsequently in response to a secretagogue (23) .
A family of integrins apparently restricted to leukocytes is comprised of CDlla/CD18 (LFA-1), CDllb/CD18 (Macd, complement receptor type 3), and CDllc/CD18 (p150,95) (34, 54) . Leukocyte adhesion deficiency (LAD) is a genetic disease resulting from markedly decreased cell surface expression of all three of these heterodimers, a consequence of deficiency or abnormality in mRNA for CD18 (34) . The function of CDll/CD18 molecules in cell adhesion has been inferred from the defects displayed by PMN of children with LAD or by normal PMN treated with anti-CDll or anti-CD18 antibodies (5, 11, 19, 26, 47, 59, 69) . PMN in LAD patients migrate poorly through tissues to sites of inflammation, and, like normal PMN treated with anti-CDll or anti-CD18 antibodies, attach and spread poorly in vitro. The in vitro studies have dealt with adherence of PMN to surfaces of nonphysiologic or complex composition: uncoated glass, plastic, or nylon wool; glass or plastic coated with serum; or cultured endothelial cells. Four specific protein ligands for CD11/CD18 have been identified: C3bi (65), ICAM-1 (39), coagulation factor X (4), and fibrinogen (FBG) (2, 68). Of these, only FBG can be considered a matrix protein. Thus, while it is likely that CD11/CD18 molecules interact with matrix components, there is little information on the specificity of CDll/CD18 integrins for individual proteins of extracellular matrix.
Using PMN from children with LAD, normal PMN treated with anti-integrin antibodies, and surfaces coated with purified matrix proteins, the present work shows that solid-phase FBG, thrombospondin, laminin, fibronectin, and vitronectin capacitate PMN to secrete hydrogen peroxide in response to cytokines. Each of these interactions requires expression of CDll/CD18 molecules on the PMN.
Materials and Methods

PMN
Donors of venous blood (collected with heparin) were three children with LAD whose clinical histories have been described (Detmers, P., S. D. Wright, E. Olsen-Egbert, R. Adamowski, Z. Chad, L. B. Kabbash, and Z. A. Cohn, manuscript in preparation), the parents of one of them, three other children referred for evaluation of leukocyte function defects, and seven healthy adults. Blood from the LAD patients and a normal donor was collected in Montreal, brought to New York by courier, and processed within •5 h of collection, together with blood that was processed immediately after collection from an additional normal donor in New York. Results were comparable for either source of normal donors' cells. For assays of H202 release, PMN were isolated on a one-step Ficoll-Hypaque gradient (Nentrophil Isolation Medium; Los Alamos Diagnostics, Los Alamos, NM) as described (40) , with the following modification. For patients with marked leukocytosis, the ratio of leukocytes to surface area of the interface was adjusted by layering 0.25 ml blood on 4 ml of isolation medium in a 15-ml tube, or 61.4 ml blood on 10 ml of isolation medium in a 50-ml tube. PMN (/>98% PMN, 62% lymphocytes) were washed and resuspended at 7.5 x IOS/ml in Krebs-Ringer phosphate buffer with glucose (KRPG) (40) . For determination of CDII/CDI8 levels, PMN were purified on a two-step Ficoll-Hypaque gradient as described (24) and resuspended in RPMI containing human serum albumin and aprotinin. Levels of CDlla, CDllb, CDllc, and CD18 on the surface of unstimulated PMN were measured by flow cytometry using mAbs TS1/22, OKM10, Lee M5, and IB4, respectively. In addition, phorbol myristate acetate (PMA) was added to mobilize possible intracellular reserves of CDll/CDI8 molecules to the cell surface (7, 10, 53) , as monitored by rosetting of erythrocytes coated with complement component C3bi. By both assays, CDI1/CDI8 molecules were ;~96% deficient on cells from each of the three LAD patients, were not measured but presumed normal on cells from two of the healthy adults, and were documented to be normal on PMN of all other donors. Vitronectin (VN); purified from human plasma by mAb and heparin affinity chromatography (27); 1.5-4.0/~g in KRI~. The FBG, FN, LAM, TSP, and VN each gave only the expected bands on polyacrylamide gel electropboresis. In other wells, 250 ~g fatty acid/50 ~tl methanol was added and the plates placed in a vacuum dessicator until the solvent evaporated. All plates were then incubated in humidified 5% CO2/95% air for 1-2 h. Wells containing protein were washed three times with 0.9% NaCI. Each well was then given 100/,1 of KRPG containing 2.4-3.5 nmol scopoletin, 0.5/~g of horseradish peroxidas¢, and 1 mM NaN3 (reaction solution). Triggering agents and antibodies were added in 10/~1. Plates were incubated at 37"C in air for 30 min before addition of cells (1.5 x 104/20/zl per well).
Preparation of Surfaces
Treatment of PMN with Antibodies
PMN were exposed to the antibodies listed in Table I while in agitated suspension in FBS-coated tubes as follows. Polypropylene microfuge tubes (Brinkmann Instruments Co., Westbury, NY) were coated with FBS by endover-end rotation at 3-/°C for 1 h. The tubes were washed extensively with 0.9 % NaC1. Antibodies were added (where indicated, addition of antibodies was delayed), followed by PMN to a final concentration of 7.5 × 105/ml in KRPG in a volume of 0.5-1.2 ml per tube of 1.5 ml capacity, or 0.24-0.38 ml per tube of 0.5 ml capacity. The tubes were shaken mechanically at 150 horizontal cycles/rain at 37°C for 90 rain. 20/~1 of cell suspension was then transferred to each well. Wells contained sufficient additional antibody to maintain the stated concentration. In some experiments with antiserum, PMN were washed after preincubation, and antiserum was not added to the wells, to avoid coating the wells with serum proteins. Bubbles in the wells were popped with a 26-gange needle to avoid fluorescence artefacts. PMN preincubated as described above could release as much H202 in response to PMA as PMN from the same preparations tested without preincubation. However, results were markedly inferior if the cell density during preincuhation was fivefold lower, the volume of cell suspension per tube threefold lower, the agitation 1.4-fold faster, the tube made of polystyrene, the coating with FBS omitted, or the suspension allowed to remain stationary at any time before the cells were transferred to the plates. In each experiment it was demonstrated that antibody treatment itself elicited no peroxide release.
1-1202 Release
Triggering agents included pure, recombinant (r) TNFot and frNF/~ (Genentech, Inc., South San Francisco, CA), rCSF-GM and rCSF-G (Amgan, Inc., Thousand Oaks, CA, and Genetics Institute, Cambridge, MA), and PMA. The cytokines have been described (40, 41) . Except in dose-response studies, all triggering agents were used at 100 ng/ml, which affords a maximal response (40, 41) . H202 release was measured at 15-rain intervals during a 2-h incubation in air at 37°C by the decrease in fluorescence of seopoletin as measured by a plate-reading fluorimeter (Flow Laboratories, Inc., McLean, VA). Results were calculated as described (21) . Each condition was tested in triplicate. When most of the SEM within one experiment were smaller than the symbols used in the figure, SEM have not been displayed. Where pooled data are reported, they represent means + SEM from the indicated number of separate experiments, each datum being the mean of triplicates from one experiment.
TNF Receptors
Specific binding of 125I-rTNFt~ to PMN was measured as reported (48) . In brief, 2 x l0 s PMN in 0.2 ml KRPG containing 5 mM NaN3 and 10% FBS were incubated with 125I-rTNFa (4 x los cpm) on a rocking platform for 4 h at 4°C with or without 100-fold excess of unlabeled r'I'NF~ washed four times by centrifugation, and counted in a gamma spectrometer.
Reagents
Where not otherwise stated, reagents were from Sigma Chemical Co. Bacterial lipopolysaccharide contamination of reagents was monitored by the chromogenic limulus amoebocyte lysate test (Whittaker M. A. Bioproducts, Walkersville, MD) and found not to exceed 20 pg/ml at the concentrations used.
Results
Previous studies (40, 41; Nathan, C., unpublished observations) established that uncoated polystyrene or glass surfaces 
Cytokine-stimulated HzD2 Secretion Specifically Requires Adherence to Surfaces Coated with Certain Proteins
To test the specificity of adherence to matrix proteins for enabling a response, we compared frNF~induced H202 secretion from PMN on plastic surfaces coated with FBS or FN to their response on surfaces coated with lipids. The PMN from three other children and from the healthy parents of one of the subjects. The normality or near normality of the PMA-induced respiratory burst of adherent LAD PMN was consistent with previous comparisons of normal and LAD PMN in suspension, under conditions where smaller amounts of respiratory burst products were measured during much shorter periods, usually <5 min (5, 11, 19, 42) . A finding of special importance for the present analysis was that uncoated polystyrene triggered H202 release from the PMN of LAD patients as well as or nearly as well as from normal PMN (Table II and Fig. 2) . Thus, in a setting where matrix proteins were not involved, PMN from children with LAD had no defect in mounting a large respiratory burst as a consequence of adherence.
In contrast, LAD cells were grossly deficient in their ability to respond to rTNFot, when assayed in plates coated with FBG, FN, TSP, VN, LAM, or FBS. Considering each combination of day, donor, and surface as a separate test, the deficient rTNFo~ response of LAD cells was demonstrated in each of 35 trials (Table III) . Fig. 2 shows such responses on each surface on which the responses of normal PMN have not been illustrated previously (40, 41) . The interpatient variability evident in Fig. 2 did not correspond to differences in surface expression of CD11/CD18 (see Materials and Methods), and remains unexplained.
The deficient response of PMN from LAD patients was not a consequence of quantitative insensitivity to rTNFot, since the defect was manifest over a 1,000-fold range of rTNFc~ concentrations on the plateau of the dose-response curve for normal PMN (Fig. 3) . In five experiments with normal PMN, multipoint binding curves indicated the presence of 1,400 5: 500 specific binding sites for TNF per cell with K~ of 3.9 (5:1.8) X 10 -9 M -l (mean 5: SEM), comparable to previous reports (e.g., reference 48). In two experiments involving 10 measurements with cells from two LAD patients at three concentrations of TNF, specific binding was 1.6-(+0.14) fold as much as binding to normal PMN. Thus, there was no evidence for a deficiency of TNF receptors on LAD PMN. Finally, LAD PMN were also deficient in their secretion of H202 in response to rCSF-G and rCSF-GM (not shown).
The deficient response of PMN from LAD patients could not be attributed to the patients' age, nor to effects of marked leukocytosis or recurrent infection, because no deficiency was evident using CDll/CD18-replete PMN from pediatric patients ranging in age from 3 days to 6 years. One of these children had marked leukocytosis and two had recurrent abscesses (Table Ill) .
Effect of Anti-CD18 or Anti-CDll mAbs on the Response of Normal PMN
The results with LAD patients raised the possibility that CDlla, CDllb, CDllc, and/or CD18 might serve as adhesion receptors for each of five matrix proteins. To test this hypothesis further and to try to determine which of the CDll/CD18 molecules was critical, we used mAbs specific to each.
In a previous study (40) , 15 rain treatment at 4°C with 2 #g/ml of the anti-CD18 mAb IB4 had no impact on the response of PMN on FBS-coated plates. We therefore exposed PMN to higher concentrations of mAb for longer times at a higher temperature. As shown in Fig. 4 a, PMN in suspension at 37°C required >168 rain pre-exposure to 30/~g/ml IB4 to block completely their subsequent response to fl'NFc~. Exposure for the same time at 4°C did not suffice, nor was preexposure fully effective unless followed by continued exposure to IB4 during the assay. With a 90-rain pre-exposure at 37°C,/>90% suppression required >t10/~g/rnl IIM (Fig. 4 b) .
Using conditions optimal for inhibition by IB4 (30 #g/ml [IB4 l,/~g/ml Dependence on duration of earlier exposure of PMN to 0 or 30 #g/ml mAb in agitated suspension at 37°C. PMN were preincubated for 90 rain with or without mAb before the start of the assay (time 0). The response of adherent cells was then followed over 120 rain, as indicated on the abscissa. For the topmost curve, no mAb was added at any time. For the other curves, 30 #g/ml mAb was present in the assay stage. The numbers to the fight of each curve specify that mAb was not also present during the preincubation (0 rain) or was added at 22.5, 45.0, or 67.5 min before time 0. In the absence of TNF (100 ng/ml), no H202 was released by PMN from any of these groups; results from one rTNF~free control are displayed. Data are means + SEM for triplicates. (B) Dependence of inhibition on the concentration of 1B4. PMN were exposed to the indicated concentration of mAb in agitated suspension at 37°C for 90 rain before the assay, as well as throughout the measurement of the response to rTNFc~ (100 ng/ml). Data are means + SEM for the number of experiments shown in parentheses, each in triplicate. H202 release was measured at time points selected by the criterion given in the legend of Table III ( PMN to release H2Oz in response to rTNF~x (100 ng/ml) during incubation on surfaces coated with the indicated proteins. PMN were exposed to 30 #g/ml of each mAb at 37°C for 90 rain in adwance of and during the assay. Results are means + SEM from the number of experiments in parentheses, each in triplicate. Time points were selected for comparison as in Table IlI . Percent inhibition was calculated in comparison to the no-antibody control after subtracting H202 released without a triggering agent.
for 90 min at 37°C before and during the assay), up to five other anti-CDll/CD18 mAbs were tested on each of the six protein-coated surfaces. As shown in Fig. 5 , IB4 inhibited the response completely on surfaces coated with FBS, FBG, LAM, and TSP, but not at all on FN, VN, or uncoated plastic. The latter results ruled out nonspecific effects of IB4 on the cells or the assay. On FBS-coated plates, an independently derived anti-CD18 mAb (60.3) was effective. However, anti-CDlla, CDllb, or CDllc mAbs were noninhibitory on any surface tested. The anti-CDllb panel included mAbs reacting with either of the known binding sites on CDllb (3, 20, 62, 65) .
Lack of Effect of Other Anti-lntegrin and Control Antibodies
The foregoing results suggested that while CD18 might be critical to PMN interaction with surfaces coated with FBS, FBG, LAM, and TSP, a different integrin might be more important in the interaction with FN and VN. However, as shown in Fig. 6 , there was no inhibition by anti-VLA-~ (which binds to FN and laminin receptors on other cell types [29] ), 7E3 (which binds gp IIb/HIa [17] , a receptor on platelets for FN, VN, FBG, and von Willebrand factor [45] ), B6H12 (which binds to a FN receptor on PMN [13] ), an antibody that binds VN receptors on a variety of cells (51), or two mAbs (OKM5, 8A6-D11) against CD36, an 88-kD glycoprotein that serves as a TSP receptor on several cell types but which has not been detected on PMN (6, 35, 52) . A variety of other mAbs that do or do not bind PMN served as further controls, emphasizing the specificity of effects seen with IB4. The tetrapeptide RGDS, a known inhibitor of many integrins (33) , interfered nonspecifically with the peroxide assay at concentrations ~>70 #g/ml and thus was not informative in this system (not shown).
Discussion
Substrate-bound matrix proteins and CDll/CD18 integrins are required for PMN to initiate a respiratory burst in response to soluble cytoldnes. The ability to secrete H202 in response to cytokines is associated with cell spreading and blocked by dihydrocytochalasin B (40, 41) , but not by colchicine or nocodazole (Nathan, C., unpublished observations). Thus, microfilaments may be involved in transmission of a capacitating signal from CDI1/CD18. This would be consistent with the association of some integrins with the actinbased cytoskeleton (33) . We do not know how adherence capacitates secretion. With T lymphocytes, antibodies that cross-link CDlla or CD18 enhance synergistically the increase in intracellular Ca ++, release of intefleukin-2, and proliferation induced by antibodies that cross-link the antigen receptor (15, 57) . With PMN, binding of CDll/CD18 to extracellular matrix proteins (but not binding by soluble mAbs) may likewise capacitate responses triggered by cytokine receptors. PMN adhesion receptors and cytokine receptors may even capacitate each other's functions reciprocally, generating positive feedback during the lag period that precedes secretion of H202. Previous observations are compatible with the occurrence of reciprocal interactions between integrins and secretagogue receptors. For example, binding of FBG to the polyspecific platelet integrin gpIIb/IIIa is essential for intracellular alkalinization induced by the binding of epinephrine to the c~2 adrenergic receptor (8) , while activation of platelets with thrombin promotes association of gpIlb/IIIa with the actinbased cytoskeleton (44) .
CD18 and/or CDll may function as receptor(s) for FBG, TSE and LAM, in that surfaces coated with purified FBG, TSP, or LAM enabled PMN to respond to rrI'NFot; PMN deficient in CDll/CD18 failed to exhibit this response; and the response of normal PMN on surfaces coated with FBG, TSE or LAM was blocked specifically by the anti-CD18 mAb, IB4. All three of these matrix proteins may bind to CDll/CD18 at site(s) bound by IIM or obstructed by the binding of IB4. Alternatively, CDll/CDI8 may be required for the function of receptors for these proteins. CDll/CD18 molecules have previously been shown to bind FBG (2, 68) . In contrast, although two distinct TSP receptors have been described on cells other than PMN (6, 38) , an interaction of PMN with TSP, and the possibility that CDll/CD18 may serve as a TSP receptor, have not previously been noted. In future studies, the ability of CDll/CDI8 to bind TSP should be tested directly. PMN do bind laminin (14) . Laminin receptors have been characterized biochemically on cells other than PMN, some of the receptors having structural features of integrins (25, 49) . To our knowledge, no previous reports have raised the possibility that CDll/CD18 may serve as a laminin receptor or regulate function of laminin receptors.
PMN bind FN (13) . However, an interaction of PMN with VN has apparently not been described. The present work indicates that PMN can interact with FN and VN via receptor(s) that are probably distinct from the receptors for FBG, TSP, and LAM, and from the IB4 epitope of CD18. This interpretation hinges on results that are seemingly paradoxical. On the one hand, PMN could not respond to rTNF~ on surfaces coated with FN or VN if the PMN were genetically deficient in CD11/CDI8. On the other hand, treatment of normal PMN with mAb IB4 did not interfere with the ability of FN or VN to support a cytokine response. Of several possible explanations, we will discuss two for which there is precedent.
First, there may be FN and VN receptor(s) that are structurally distinct from CD11/CD18, but whose signals must be transmitted via a CDll-or CD18-dependent pathway. It is known that information can be exchanged between integrin molecules: adherence of macrophages to a FN-coated surface capacitates CDllb/CD18 molecules on the nonadherent surface of the cell to mediate the ingestion of C3bi-coated erythrocytes (63) . Alternatively, CD18 may be part of the FN and VN receptor(s) of PMN, but FN and VN may bind to site(s) distinct from those recognized by or obstructed by mAb 1B4. A noncross-reactive pattern of inhibition by different mAbs supports the inference that CDllb has two to three different binding sites for the ligands C3bi, FBG (2), and phosphorylated microbial carbohydrates (62) .
Two observations suggest that CDll/CD18 molecules can capacitate PMN to secrete H202 in response to rTNFot by serving as adhesion receptors in their own right, rather than solely by mediating or regulating the function of other adhesion receptors. First, PMN required CDll/CD18 to respond on surfaces coated with FBG; CDll/CD18 molecules seem to comprise all demonstrable PMN binding sites for FBG (2, 68) . Second, surfaces coated with complement component C3bi also capacitated PMN to respond to rTNFo~ (Nathan, C., and S. Wright, unpublished observations); CDll/CD18 molecules comprise all detectable binding sites on PMN for C3bi (62, 64) .
The present study did not find evidence for the involvement of integrins other than CDll/CD18 in the FN and VN receptor activity of PMN. Three families of integrins with distinct/3 chains are presently recognized:/31 or VLA, which includes at least two FN receptors, termed VLA-5 (ECMR VI) and ECMR I (28, 60);/32, consisting of the CDll/CD18 molecules; and/33, which includes a VN receptor and gp IIb/IIIa, which binds both FN and VN. The/31 family is unlikely to participate in the response of PMN to matrix components, since these molecules have been considered absent from PMN (28, 60) . In a recent study, flow cytometry detected weak binding of an anti-VLA-fl mAb to PMN, but without any difference between PMN from normals and PMN from the LAD patients studied here (Wright, S. D., P. A. Detmers, R. Adamowski, Z. Chad, L. G. Kabbash, and M. J. Pabst, manuscript in preparation). In the present work, a polyclonal antibody to the/31 chain did not inhibit the response of PMN on surfaces coated with FN or VN. Similarly, with regard to r3 integrins, PMN are not thought to express gp Ilb/HIa, and neither a polyclonal anti-VN receptor antibody nor a mAb to gp IIb/IHa was inhibitory. A FNbinding protein has been purified from PMN, which reacts with a polyclonal anti-/33 antibody (13); a mAb against this protein had no effect on the response of PMN on FN. Of course, some of these reagents, particularly the mAbs, could have bound to a relevant receptor and failed to inhibit its function. Thus, these studies do not rule out the participation of known integrins. Likewise, the possibility cannot be excluded that the underlying defects in LAD PMN may affect not just CD18 mRNA (34) but also other molecules involved in adhesion.
Inhibition of the cytokine response required prolonged preexposure to anti-CD18 mAb at 37°C and the continued presence of high concentrations of antibody throughout the assay. This might reflect that PMN contain a large intracellular store of CDll/CD18 and can mobilize it to the cell surface (7, 10, 53) . Engagement of a small fraction of CDll/CD18 molecules may be sufficient for a maximal response, and CD11/CD18 molecules exteriorized at the site of contact with the substrate may be partly protected from antibodies (61, 67) . Prolonged preincubation at 37°C may permit endocytosed mAb to complex with intracellular CD18 before CDll/ CD18 molecules are mobilized to the protected sites where PMN make contact with the matrix protein-coated surface.
It now appears that a secretory response of PMN can be controlled by ligation of three classes of receptors at the same time on the same cell. The ability of PMN to secrete large amounts of H202 in response to TNFa//3, CSF-G, and CSF-GM is presumably controlled by the known receptors for these cytokines (43, 48, 58) . This response is suppressed by adenosine at levels found in plasma (22) , an effect most likely mediated through the A2 receptor (18) . The present results indicate that a third type of receptor, CD11/CD18, is required to capacitate this secretory response. The respiratory burst, which serves to kill microbes, can also cause or promote damage to host tissue (31) . For PMN in circulation, lack of a positive signal from adhesion receptors may lessen the likelihood of secretion in response to cytokines that have spilled into the blood from inflammatory sites. The secretory response to cytokines may normally be confined instead to PMN that have aggregated, adhered, or emigrated in a manner dependent in large part on CD11/CD18. Consistent with this speculation, experimental animals have been protected from inflammatory tissue damage by adminstration of anti-CD18 mAb (56) . This work was supported by National Institutes of Health grants CA-45218 (to C. Nathan), CA43610 (to C. Nathan), CA42507 (to J. Gailit), CA30199 (to J. Gailit), HL01567 (to A. Asch), AI22003 (to S. Wright), and AI24775 (to S. Wright). S. Wright is an Established Investigator of the American Heart Association.
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